Please use this identifier to cite or link to this item:
標題: Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14
作者: Huang, J.R.
Wu, C.C.
Hou, R.C.W.
Jeng, K.C.
關鍵字: bromelain;monocytes;NF-kappa B;COX-2;TXB2;MAP kinases;CD14;nf-kappa-b;gene-expression;mononuclear-cells;in-vitro;activation;induction;kinase;cox-2;inflammation;macrophages
Project: Immunological Investigations
期刊/報告no:: Immunological Investigations, Volume 37, Issue 4, Page(s) 263-277.
Bromelain has been reported to have anti-inflammatory and immunomodulatory effects. However, the anti-inflammatory mechanism of bromelain is unclear. Therefore, we investigated the effect of bromelain on cytokine production from lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells (PBMC) and monocytic leukemia THP-1 cells. The result showed that bromelain (50-100 mu g/ml) significantly and reversibly reduced tumor necrosis factor (TNF)-alpha interleukin- (IL)-1 beta and IL-6 from LPS-induced PBMC and THP-1 cells. This effect was correlated with reduced LPS-induced TNF-alpha mRNA and NF-kappa B activity in THP-1 cells. In addition, bromelain dose-dependently inhibited LPS-induced prostaglandin E-2, thromboxane B-2 and COX-2 mRNA but not COX-1 mRNA. Importantly, bromelain degraded TNF-alpha and IL-1 beta molecules, reduced the expression of surface marker CD14 but not Toll-like receptor 4 from THP-1 cells. Taken together, the results suggest that the suppression of signaling pathways by bromelain's proteolytic activity may contribute to the anti-inflammatory activity of bromelain.
ISSN: 0882-0139
DOI: 10.1080/08820130802083622
Appears in Collections:期刊論文

Show full item record

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.